KatharineBattMDMSc(She/Her)

Hematology • Raleigh, NC

Clotting Disorder, Hemophilia & Bleeding Disorder

Scientific Advisor

Join to view full profile

Dr. Batt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Batt's full profile

Already have an account?

Office
Sprouts Healthcare Consulting
Raleigh, NC 27612

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2010 - 2013
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Hospice and Palliative Medicine, 2009 - 2010
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2006 - 2009
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2006

Certifications & Licensure

NC State Medical License 2013 - 2026
NY State Medical License 2006 - 2013
National Board of Physicians and Surgeons Hematology
National Board of Physicians and Surgeons Hospice and Palliative Medicine
National Board of Physicians and Surgeons Internal Medicine

Publications & Presentations

PubMed

The Importance of Clinical Context and Consistency in Methodology When Using Matching-Adjusted Indirect Comparisons (MAICs) to Compare Outcomes.
Katharine Batt, Robert Klamroth, Maria Elisa Mancuso, Andreas Tiede, Lorenzo G Mantovani
International Journal of General Medicine. 2024-01-01
1 citations
Gaining consensus around patient risk groups and prognostic profiles to guide CMV management among patients with solid organ transplant: Insights from a Delphi panel w...
Priti Pednekar, Marlon Graf, Rifat Tuly, Katharine Batt, Connie Wang
Clinical Transplantation. 2023-08-01
Evaluating the financial impact of utilizing recombinant porcine factor VIII or recombinant FVIIa for patients with acquired hemophilia A.
Michael Bullano, Christina Cool, Bob G Schultz, Sneha Durgapal, Naomi Sacks
Expert Review of Pharmacoeconomics & Outcomes Research. 2023-02-01

Abstracts/Posters

Quantifying the Economic Burden of Myelodysplastic Syndromes Among Elderly US Patients
Katharine Batt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Economic Burden of Bronchiolitis Obliterans Syndrome (BOS) Following Allogeneic Hematopoietic Stem Cell Transplant (alloHSCT) in Patients with Commercial Insurance in ...
Katharine Batt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

We Need More Studies of People with Mild HemophiliaFebruary 25th, 2022
Takeda Drives Continued Scientific Leadership Through Real-World Evidence in Rare Hematological Diseases at ASH 2021December 13th, 2021
ASH 2016 – Saturday, December 3December 3rd, 2015
Join now to see all